Cite
HARVARD Citation
Labriola, M. et al. (2020). Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma. Journal for immunotherapy of cancer. 8 (1), p. . [Online].